Inflammatory markers predict insulin sensitivity in active rheumatoid arthritis but not in psoriatic arthritis
Submitted: 8 August 2017
Accepted: 17 May 2018
Published: 20 December 2018
Accepted: 17 May 2018
Abstract Views: 1199
PDF: 804
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Similar Articles
- M. Fabris, B. Tolusso, E. Gremese, P. Tomietto, G. Ferraccioli, Analysis of the kinetic of expression of tristetraprolin and HuR by rheumatoid arthritis patients pheripheral blood mononuclear cells stimulated with lipopolysaccharide , Reumatismo: Vol. 56 No. 2 (2004)
- G. Ferraccioli, Reconstructing the pyramid as a therapeutic approach to rheumatoid arthritis , Reumatismo: Vol. 56 No. s1 (2004)
- Giuseppe D'Alessandro, Maria Rosaria Bianco, Spiridon Politis, Celestino Ferrandina, Giuseppe Rossi, Emanuele Altomare, Case report: AREB in a patient with rheumatoid arthritis treated with methotrexate and infliximab , Reumatismo: Vol. 58 No. 1 (2006)
- C. Pizzorni, M.E. Secchi, M. Cutolo, Leishmaniasis in rheumatoid arthritis , Reumatismo: Vol. 59 No. 3 (2007)
- W. Grassi, R. De Angelis, Clinical features of gout , Reumatismo: Vol. 63 No. 4 (2011): Special issue • Microcrystalline Arthritis
- M. Bellan, D. Soddu, E. Zecca, A. Croce, R. Bonometti, R. Pedrazzoli, D. Sola, C. Rigamonti, L.M. Castello, G.C. Avanzi, M. Pirisi, P.P. Sainaghi, Association between red cell distribution width and response to methotrexate in rheumatoid arthritis , Reumatismo: Vol. 72 No. 1 (2020)
- V. Riccieri, A. Spadaro, E. Taccari, A. Zoppini, I. Markus, M. Sesztak, J. Ortutay, E. Koo, Immunohistochemical analysis of the expression of main adhesion molecules and tumor necrosis factors in the synovial membrane of psoriatic arthritis , Reumatismo: Vol. 55 No. 3 (2003)
- D. Marotto, M.E. Nieddu, A. Cossu, A. Carcassi, Prevalence of rheumatoid arthritis in North Sardinia: the Tempio Pausania’s study , Reumatismo: Vol. 57 No. 4 (2005)
- G. Pasero, P. Marson, short history of anti-rheumatic therapy. IV. Corticosteroids , Reumatismo: Vol. 62 No. 4 (2010)
- G. Carlino, M. Fornaro, L. Santo, R. Bucci, A. Semeraro, L. Quarta, F. D'Onofrio, A. Marsico, C. Zuccaro, P.C. Falappone, D. Mazzotta, F.P. Cantatore, M. Muratore, F. Iannone, Occult HBV infection may negatively impact on drug survival in patients with rheumatoid arthritis on treatment with a first biologic drug. An appraisal from the Biologic Apulian Registry (BIOPURE) , Reumatismo: Vol. 71 No. 1 (2019)
<< < 18 19 20 21 22 23 24 25 26 27 > >>
You may also start an advanced similarity search for this article.